Company: BDRX
Filing Date: 2025-12-11
Form Type: F-1/A
Source: 0001214659-25-017944
Chunk: 156

Company: Biodexa Pharmaceuticals Plc
Filing Date: 2025-12-11
Form: F-1/A
Chunk 156
---
 the offering of such securities 
 at that time shall be deemed to be the initial bona fide offering thereof.                                                                   |

| (3) | To remove from registration by means of a post-effective amendment any of the securities being registered 
 which remain unsold at the termination of the offering.                                                   |

| (4) | To file a post-effective amendment to the registration statement to include any financial statements required                             
 by Item 8.A. of Form 20-F at the start of any delayed offering or throughout a continuous offering. Financial statements and information  
 otherwise required by Section 10(a)(3) of the Act need not be furnished, provided that the registrant includes in the                     
 prospectus, by means of a post-effective amendment, financial statements required pursuant to this paragraph (a)(4) and other information 
 necessary to ensure that all other information in the prospectus is at least as current as the date of those financial statements.        |

| (5) | That, for the purpose of determining liability under the Securities Act of 1933 to any purchaser: |

| (i) | Each prospectus filed by the registrant pursuant to Rule 424(b)(3) shall be deemed to be part of the registration 
 statement as of the date the filed prospectus was deemed part of and included in the registration statement; and  |

| (ii) | Each prospectus required to be filed pursuant to Rule 424(b)(2), (b)(5), or (b)(7) as part of a registration                                  
 statement in reliance on Rule 430B relating to an offering made pursuant to Rule 415(a)(1)(i), (vii), or (x) for the purpose of providing     
 the information required by section 10(a) of the Securities Act of 1933 shall be deemed to be part of and included in the registration        
 statement as of the earlier of the date such form of prospectus is first used after effectiveness or the date of the first contract of        
 sale of securities in the offering described in the prospectus. As provided in Rule 430B, for liability purposes of the issuer and any        
 person that is at that date an underwriter, such date shall be deemed to be a new effective date of the registration statement relating       
 to the securities in the registration statement to which that prospectus relates, and the offering of such securities at that time shall      
 be deemed to be the initial bona fide offering thereof. Provided, however, that no statement made in a registration statement or